Small Molecules in Oncology

1. Imatinib Mesylate
Cornelius F. Waller

2. Erlotinib
M. Steins, M. Thomas, M. Geißler

3. Axitinib (AG-013736)
Ronan Joseph Kelly, Olivier Rixe

4. Lapatinib
Tanja Schneider-Merck, Martin Trepel

5. Sorafenib
Jens Hasskarl

6. Sunitinib
Daniel Y. C. Heng, Christian Kollmannsberger

7. Dasatinib
Markus Lindauer, Andreas Hochhaus

8. Nilotinib
Alfonso Quintás-Cardama, Theo Daniel Kim, Vince Cataldo, Philipp Coutre

9. Bosutinib
Gunhild Keller, Philippe Schafhausen, Tim H. Brümmendorf

10. Decitabine
Michael Daskalakis, Nadja Blagitko-Dorfs, Björn Hackanson

11. 5-Azacytidine/Azacitidine
Antonia Müller, Mareike Florek

12. Bortezomib
Hermann Einsele

13. Temsirolimus
Christian Stock, Massimo Zaccagnini, Michael Schulze, Dogu Teber, Jens J. Rassweiler

14. Danusertib (formerly PHA-739358) – A Novel Combined Pan-Aurora Kinases and Third Generation Bcr-Abl Tyrosine Kinase Inhibitor
Artur Gontarewicz, Tim H. Brümmendorf

15. BI_2536 - Targeting the Mitotic Kinase Polo-Like Kinase 1 (Plk1)
R. Wäsch, J. Hasskarl, D. Schnerch, M. Lübbert

16. Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy
Alexander Röth, Calvin B. Harley, Gabriela M. Baerlocher

17. GDC-0449 - Targeting the Hedgehog Signaling Pathway
Christine Dierks

Keywords: Medicine & Public Health, Oncology, Cancer Research